肾母细胞瘤治疗研究进展

参考文献/References:

1 Stokes CL,Stokes WA,Kalapurakal JA,et al.Timing of radiation therapy in pediatric Wilms tumor:A Report From the National Cancer Database[J].Int J Radiat Oncol Biol Phys,2018,101(2):453-461.DOI:10.1016/j.ijrobp.2018.01.110.
2 Leslie SW,Murphy PB.Cancer,Wilms(Nephroblastoma)[M/OL].(2019-05-02)[2019-08-01].https://www.ncbi.nlm.nih.gov/books/NBK442004/.
3 Irtan S,Ehrlich PF,Pritchard-Jones K.Wilms tumor:"State-of-the-art" update,2016[J].Semin Pediatr Surg,2016,25(5):250-256.DOI:10.1053/j.sempedsurg.2016.09.003.
4 Kieran K,Ehrlich PF.Current surgical standards of care in Wilms tumor[J].Urol Oncol,2016,34(1):13-23.DOI:10.1016/j.urolonc.2015.05.029.
5 Lopes RI,Ming J,Koyle MA,et al."Zero-ischemia" laparoscopic-assisted partial nephrectomy for the management of selected children with Wilms tumor following neoadjuvant chemotherapy[J].Urology,2017,100:103-110.DOI:10.1016/j.urology.2016.08.051.
6 Davidoff AM,Giel DW,Jones DP,et al.The feasibility and outcome of nephron-sparing surgery for children with bilateral Wilms tumor.The St Jude Children’s Research Hospital experience:1999-2006[J].Cancer,2008,112(9):2060-2070.DOI:10.1002/cncr.23406.
7 侯培民,王东明,张强业,等.腔镜技术在小儿肿瘤切除手术中的应用及技巧探讨[J].临床小儿外科杂志,2019,18(4):277-281.DOI:10.3969/j.issn.1671-6353.2019.04.006. Hou PM,Wang DM,Zhang QG,et al.Application and skill exploration of laparoscopic and thoracoscopic techniques for pediatric tumor resection[J].J Clin Ped Sur,2019,18(4):277-281.DOI:10.3969/j.issn.1671-6353.2019.04.006.
8 Lopez L,Copete M,Villamizar P.Laparoscopic nephron-sparing surgery for Wilms tumor:description of two cases[J].Cir Pediatr,2016,29(1):31-34.
9 Yadav P,Mahajan A,Kandpal DK,et al.Nephron-sparing Surgery for Syndromic Wilms’ Tumor:Robotic Approach[J].Urology,2018,116:172-175.DOI:10.1016/j.urology.2018.03.003.
10 Eriksen KO,Johal NS,Mushtaq I.Minimally invasive surgery in management of renal tumours in children[J].Transl Pediatr,2016,5(4):305-314.DOI:10.21037/tp.2016.09.04.
11 Warmann SW,Godzinski J,Van Tinteren H,et al.Minimally invasive nephrectomy for Wilms tumors in children-data from SIOP 2001[J].J Pediatr Surg,2014,49(11):1544-1548.DOI:10.1016/j.jpedsurg.2014.06.005.
12 Kumar A,Bakhshi S,Agarwala S.Is pre-operative chemotherapy desirable in all patients of Wilms’ tumor?[J].Indian J Pediatr,2017,84(9):709-714.DOI:10.1007/s12098-017-2410-5.
13 Manzoor R,Yasmeen N.Upfront nephrectomy versus preoperative chemotherapy in Wilm’s tumour[J].J Ayub Med Coll Abbottabad,2019,31(1):104-107.
14 Dome JS,Perlman EJ,Graf N.Risk stratification for Wilms tumor:current approach and future directions[J].Am Soc Clin Oncol Educ Book,2014,215-223.DOI:10.14694/EdBook_AM.2014.34.215.
15 Ko EY,Ritchey ML.Current management of Wilms’ tumor in children[J].J Pediatr Urol,2009,5(1):56-65.DOI:10.1016/j.jpurol.2008.08.007.
16 Aldrink JH,Heaton TE,Dasgupta R,et al.Update on Wilms tumor[J].J Pediatr Surg,2019,54(3):390-397.DOI:10.1016/j.jpedsurg.2018.09.005.
17 中国抗癌协会小儿肿瘤专业委员会.儿童肾母细胞瘤诊断治疗建议(CCCG-WT-2016)[J].中华儿科杂志,2017,55(2):90-94.DOI:10.3760/cma.j.issn.0578-1310.2017.02.007. Chinese Children Cancer Group of Chinese Anti-Cancer Association.Recommendations for the diagnosis and treatment of pediatric Wilms’ tumor(CCCG-WT-2016)[J].Chin J Pediatr,2017,55(2):90-94.DOI:10.3760/cma.J.i SSN.0578-1310.2017.02.007.
18 Friesenbichler W,Krizmanich W,Lakatos K,et al.Outcome of two patients with bilateral nephroblastomatosis/Wilms tumour treated with an add-on 13-cis retinoic acid therapy-Case report[J].Pediatr Hematol Oncol,2018,35(3):218-224.DOI:10.1080/08880018.2018.1515284.
19 Schiavetti A,Varrasso G,Collini P,et al.Vincristine,irinotecan,and bevacizumab in relapsed Wilms tumor with diffuse anaplasia[J].J Pediatr Hematol Oncol,2018,40(4):331-333.DOI:10.1097/mph.0000000000000934.
20 Zhang M,Xue E,Shao W.Andrographolide promotes vincristine-induced SK-NEP-1 tumor cell death via PI3K-AKT-p53 signaling pathway[J].Drug Des Devel Ther,2016,10:3143-3152.DOI:10.2147/DDDT.S113838.
21 Wang J,Li Y,Ma F,et al.Inhibitory effect of Par-4 combined with cisplatin on human Wilms’ tumor cells[J].Tumour Biol,2017,39(7):101010428317716689.DOI:10.1177/1010428317716689.
22 Yuan LQ,Wang C,Zhu K,et al.The antitumor effect of static and extremely low frequency magnetic fields against nephroblastoma and neuroblastoma[J].Bioelectromagnetics,2018,39(5):375-385.DOI:10.1002/bem.22124.
23 Wang J,Zhang N,Qu H,et al.Inhibitory effect of STAT3 gene combined with CDDP on growth of human Wilms tumour SK-NEP-1 cells[J].Biosci Rep,2016,36(3):e00342.DOI:10.1042/bsr20160072.
24 Zaghloul MS.Intensity modulated radiotherapy(IMRT) for pediatric cancer patients:the advantage and fear of second malignant neoplasm[J].J Egypt Natl Canc Inst,2013,25(1):1-3.DOI:10.1016/j.jnci.2012.11.002.
25 Papachristofilou A,Hottinger AL,Weinhold O,et al.Heart-sparing volumetric modulated arc therapy for whole lung irradiation[J].Strahlenther Onkol,2019,195(1):77-82.DOI:10.1007/s00066-018-1363-6.
26 Fracchiolla F,Dionisi F,Giacomelli I,et al.Implementation of proton therapy treatments with pencil beam scanning of targets with limited intrafraction motion[J].Phys Med,2019,57:215-220.DOI:10.1016/j.ejmp.2019.01.007.
27 Guerreiro F,Seravalli E,Janssens GO,et al.Potential benefit of MRI-guided IMRT for flank irradiation in pediatric patients with Wilms’ tumor[J].Acta Oncol,2019,58(2):243-250.DOI:10.1080/0284186x.2018.1537507.
28 Shukrun R,PodeShakked N,Dekel B.Targeted therapy aimed at cancer stem cells:Wilms’ tumor as an example[J].Pediatr Nephrol,2014,29(5):815-823.DOI:10.1007/s00467-013-2501-0.
29 Maschietto M,Charlton J,Perotti D,et al.The IGF signalling pathway in Wilms tumours-a report from the ENCCA Renal Tumours Biology-driven drug development workshop[J].Oncotarget,2014,5(18):8014-8026.DOI:10.18632/oncotarget.2485.
30 Wagner KD,El Mai M,Ladomery M,et al.Altered VEGF splicing isoform balance in tumor endothelium involves activation of splicing factors Srpk1 and Srsf1 by the Wilms’ tumor suppressor Wt1[J].Cells,2019,8(1):41.DOI:10.3390/cells8010041.
31 Wang J,Fan S,Feng Y,et al.Antiangiogenic therapy for Wilms tumor in an adult and literature review[J].Anticancer Drugs,2019,30(6):640-645.DOI:10.1097/cad.0000000000000792.
32 Shibuya M.Vascular endothelial growth factor(VEGF) and its receptor(VEGFR) signaling in angiogenesis:a crucial target for anti-and pro-angiogenic therapies[J].Genes Cancer,2011,2(12):1097-1105.DOI:10.1177/1947601911423031.
33 Janku F.Phosphoinositide 3-kinase(PI3K) pathway inhibitors in solid tumors:From laboratory to patients[J].Cancer Treat Rev,2017,59:93-101.DOI:10.1016/j.ctrv.2017.07.005.
34 Haddadi N,Lin Y,Travis G,et al.PTEN/PTENP1:’Regulating the regulator of RTK-dependent PI3K/Akt signalling’,new targets for cancer therapy[J].Mol Cancer,2018,17(1):37.DOI:10.1186/s12943-018-0803-3.
35 Polosukhina D,Love HD,Correa H,et al.Functional KRAS mutations and a potential role for PI3K/AKT activation in Wilms tumors[J].Mol Oncol,2017,11(4):405-421.DOI:10.1002/1878-0261.12044.
36 Li H,Huang D,Hang S.Salidroside inhibits the growth,migration and invasion of Wilms’ tumor cells through down-regulation of miR-891b[J].Life Sci,2019,222:60-68.DOI:10.1016/j.lfs.2019.02.052.
37 Yoshizawa S,Fujiwara K,Sugito K,et al.Pyrrole-imidazole polyamide-mediated silencing of KCNQ1OT1 expression induces cell death in Wilms’ tumor cells[J].Int J Oncol,2015,47(1):115-121.DOI:10.3892/ijo.2015.3018.
38 Markovsky E,Vax E,Ben-Shushan D,et al.Wilms tumor NCAM-expressing cancer stem cells as potential therapeutic target for polymeric nanomedicine[J].Mol Cancer Ther,2017,16(11):2462-2472.DOI:10.1158/1535-7163.Mct-17-0184.
39 Shi B,Li Y,Wang X,et al.Silencing of hypoxia inducible factor-1alpha by RNA interference inhibits growth of SK-NEP-1 Wilms tumour cells in vitro,and suppresses tumourigenesis and angiogenesis in vivo[J].Clin Exp Pharmacol Physiol,2016,43(6):626-633.DOI:10.1111/1440-1681.12575.
40 Maturu P,Jones D,Ruteshouser EC,et al.Role of Cyclooxygenase-2 Pathway in Creating an Immunosuppressive Microenvironment and in Initiation and Progression of Wilms’ Tumor[J].Neoplasia,2017,19(3):237-249.DOI:10.1016/j.neo.2016.07.009.
41 田艳秋,李彦强,周家华,等.扩增活化的自体淋巴细胞对肾母细胞瘤的影响[J].广东医学,2017,38(z1):19-21.DOI:10.13820/j.cnki.gdyx.2017.s1.006. Tian YQ,Li YQ,Zhou JH,et al.Effect of amplified activated autologous lymphocytes on renal blastoma[J].Guangdong Medical Journal,2017,38(z1):19-21.DOI:10.3969/j.issn.1001-9448.2017.z1.006.
42 Holl EK,Routh JC,Johnston AW,et al.Immune expression in children with Wilms tumor:a pilot study[J].J Pediatr Urol,2019,15(5):441.e1-e8.DOI:10.1016/j.jpurol.2019.03.011.